Showing results (1-10 of 156) with videos related to
Sort By:
Pageof 16
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1992
Antitumour activity of folligen, a novel gonadotropin-releasing hormone analogue against DMBA-induced tumours in the ratR I Nicholson, G KériBritish Journal of Cancer|March 1, 1979
Effects of high doses of a series of new luteinizing hormone-releasing hormone analogues in intact female ratsP V Maynard, R I NicholsonEuropean Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Isolation of pMGT1: a gene that is repressed by oestrogen and increased by antioestrogens and antiprogestinsD L Manning, R I NicholsonJournal of Steroid Biochemistry|October 1, 1989
Gn-RH agonists in breast and gynaecologic cancer treatmentR I Nicholson, K J WalkerChemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1985
Influence of LH-RH agonists on the growth and hormonal environment of breast and prostate cancerR I Nicholson, K J WalkerBritish Journal of Cancer|March 1, 1979
Anti-tumour activity of ICI 118630, a new potent luteinizing hormone-releasing hormone agonistR I Nicholson, P V MaynardThe Journal of Endocrinology|April 1, 1977
Early increases in ribonucleic acid polymerase activities of dimethylbenzanthracene-induced mammary tumour nuclei in response to oestradiol-17beta and tamoxifenR I Nicholson, P Davies, K GriffithsTrends in Endocrinology and Metabolism: TEM|November 16, 2004
Zinc transporter LIV-1: a link between cellular development and cancer progressionKathryn M Taylor, S Hiscox, R I NicholsonBritish Journal of Cancer|April 20, 2004
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of actionC K Osborne, A Wakeling, R I NicholsonEuropean Urology|January 1, 1997
Androgens, androgen receptors, antiandrogens and the treatment of prostate cancerK Griffiths, M S Morton, R I NicholsonPageof 16